We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-9.07%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.64B
AUM Growth
-$613M
Cap. Flow
-$149M
Cap. Flow %
-5.64%
Top 10 Hldgs %
60.48%
Holding
145
New
10
Increased
53
Reduced
36
Closed
15

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$36.6M
2
SUZ icon
Suzano
SUZ
+$31.5M
3
LGIH icon
LGI Homes
LGIH
+$16.2M
4
ICE icon
Intercontinental Exchange
ICE
+$15.7M
5
CVNA icon
Carvana
CVNA
+$13.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.11%
2 Industrials 19.19%
3 Technology 18.33%
4 Materials 11.95%
5 Healthcare 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
76
BioCryst Pharmaceuticals
BCRX
$2.4B
$2.35M 0.09%
221,699
XGN icon
77
Exagen
XGN
$166M
$2.3M 0.09%
400,000
MRSN
78
DELISTED
Mersana Therapeutics
MRSN
$2.29M 0.09%
19,819
CTMX icon
79
CytomX Therapeutics
CTMX
$754M
$2.25M 0.09%
1,229,545
+249,460
+25% +$478K
GTH
80
DELISTED
Genetron Holdings Limited ADS
GTH
$2.24M 0.08%
438,881
ROIV icon
81
Roivant Sciences
ROIV
$26.2B
$2.06M 0.08%
505,577
+181,934
+56% +$722K
PVLA
82
Palvella Therapeutics
PVLA
$2.27B
$2.06M 0.08%
13,736
+882
+7% +$161K
BPMC
83
DELISTED
Blueprint Medicines
BPMC
$2.02M 0.08%
40,004
+12,883
+48% +$755K
TKNO icon
84
Alpha Teknova
TKNO
$347M
$2.01M 0.08%
239,594
+70,357
+42% +$742K
AMAT icon
85
Applied Materials
AMAT
$428B
$1.97M 0.07%
21,644
+7,359
+52% +$807K
INBX
86
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.82M 0.07%
160,099
+73,170
+84% +$1.08M
YMM icon
87
Full Truck Alliance
YMM
$9.99B
$1.8M 0.07%
199,091
PRTA icon
88
Prothena Corp
PRTA
$450M
$1.64M 0.06%
60,512
OMIC
89
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.64M 0.06%
14,311
+5,530
+63% +$649K
AFMD
90
DELISTED
Affimed
AFMD
$1.6M 0.06%
+57,913
New +$1.98M
RCUS icon
91
Arcus Biosciences
RCUS
$3.64B
$1.57M 0.06%
61,780
ZYME icon
92
Zymeworks
ZYME
$1.67B
$1.57M 0.06%
295,486
+60,187
+26% +$364K
CYPH
93
Cypherpunk Technologies Inc
CYPH
$73.3M
$1.53M 0.06%
132,795
DNLI icon
94
Denali Therapeutics
DNLI
$3.97B
$1.5M 0.06%
50,971
PYPL icon
95
PayPal
PYPL
$50.5B
$1.46M 0.06%
20,870
+7,413
+55% +$643K
ELUT icon
96
Elutia
ELUT
$37.6M
$1.33M 0.05%
188,181
ALEC icon
97
Alector
ALEC
$199M
$1.07M 0.04%
105,614
ABSI icon
98
Absci
ABSI
$1.51B
$989K 0.04%
297,823
FWONK icon
99
Liberty Media Series C
FWONK
$25.8B
$971K 0.04%
15,825
-206
-1% -$12.6K
EBAY icon
100
eBay
EBAY
$49.8B
$945K 0.04%
22,679

Similar funds

Platinum Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Platinum Investment Management held 145 positions worth $2.64B, down 19% from $3.26B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Platinum Investment Management withdrew a net $149M in Q2 2022, closing 15 positions and reducing 36 holdings. Its most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $7.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

Against the trend, Platinum Investment Management opened a new position in Six Flags Entertainment Corp. worth $4.77M.

  • Platinum Investment Management's largest Q2 2022 buy was Six Flags Entertainment Corp.: 219,665 shares worth $4.77M.
  • Platinum Investment Management added most to Alibaba in Q2 2022, an estimated $36.6M increase.
  • Platinum Investment Management's biggest Q2 2022 reduction was Trip.com Group, cutting an estimated $95.9M.
  • Platinum Investment Management fully exited Syneos Health, Inc. Class A Common Stock in Q2 2022, selling an estimated $7.6M.
  • Platinum Investment Management's ten largest holdings make up 60% of its $2.64B portfolio in Q2 2022.
  • Platinum Investment Management opened 10 new positions and closed 15 in Q2 2022.
  • Platinum Investment Management's portfolio value fell 19% quarter-over-quarter to $2.64B.

Based on Platinum Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.